Hospital
Endeavor Health Clinical Operations
Endeavor Health Clinical Operations was paid $7.18M by Medicaid between Jan 2018 and Feb 2024, across 106 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 87% of everything it billed.
33Billing provider infoENDEAVOR HEALTH CLINICAL OPERATIONS
EVANSTON, IL 60201
EVANSTON, IL 60201
33aNPI1184670549assigned 05/26/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.18M
24GClaims182,015
24DCodes billed106
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#4 of 129
Median peer was paid$547K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 76,748 | $3.30M | |
| 2019 | 84,442 | $3.21M | |
| 2020 | 20,579 | $663K | |
| 2024incomplete | 246 | $457.56 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 87% | 95,608 | 11,821 | $6.25M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.1% | 11,733 | 1,989 | $153K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.7% | 2,281 | 2,224 | $121K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 5,470 | 2,601 | $67K |
| 73630 | <1% | 2,230 | 1,411 | $30K | |
| 73610 | <1% | 1,561 | 1,073 | $30K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,155 | 2,040 | $28K |
| 73564 | <1% | 1,699 | 1,142 | $28K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,231 | 2,149 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,185 | 2,060 | $22K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,377 | 1,165 | $21K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,013 | 1,929 | $21K |
94 more codes
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,373 | $21K |
| 73110 | <1% | 1,322 | $20K | |
| 73130 | <1% | 1,588 | $19K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 673 | $19K |
| 73030 | <1% | 1,259 | $18K | |
| 73502 | <1% | 948 | $18K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 488 | $16K |
| 72110 | <1% | 895 | $15K | |
| 73562 | <1% | 1,077 | $15K | |
| 85610 | <1% | 6,149 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 821 | $12K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 750 | $12K |
| 80053 | Comprehensive metabolic panel | <1% | 3,451 | $12K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,058 | $12K |
| 97165 | <1% | 1,105 | $11K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,933 | $11K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,662 | $10K |
| 86480 | <1% | 183 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,312 | $8K |
| 97166 | <1% | 553 | $7K | |
| 83655 | <1% | 708 | $7K | |
| 92523 | <1% | 380 | $7K | |
| 73140 | <1% | 663 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 309 | $6K |
| 92134 | <1% | 660 | $5K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 121 | $5K |
| 92083 | <1% | 213 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,400 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,754 | $4K |
| 84403 | <1% | 200 | $4K | |
| 72100 | <1% | 301 | $4K | |
| 93296 | <1% | 184 | $3K | |
| 73560 | <1% | 288 | $3K | |
| 73080 | <1% | 259 | $3K | |
| 74018 | <1% | 323 | $3K | |
| 72050 | <1% | 207 | $3K | |
| 77073 | <1% | 130 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 153 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 567 | $1K |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 310 | $1K |
| 85027 | <1% | 955 | $1K | |
| 73590 | <1% | 109 | $1K | |
| 72082 | <1% | 45 | $1K | |
| 72040 | <1% | 110 | $966.47 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 688 | $960.52 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 862 | $938.55 |
| 87481 | <1% | 1,229 | $891.56 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 307 | $869.29 |
| 92133 | <1% | 164 | $788.01 | |
| 80061 | Lipid panel | <1% | 899 | $749.34 |
| 77072 | <1% | 65 | $741.00 | |
| 86800 | <1% | 93 | $627.14 | |
| 83550 | <1% | 372 | $615.39 | |
| 80177 | <1% | 125 | $602.06 | |
| 73100 | <1% | 41 | $565.13 | |
| 82728 | <1% | 478 | $524.18 | |
| 87480 | <1% | 144 | $495.35 | |
| 87510 | <1% | 144 | $482.60 | |
| 90686 | <1% | 41 | $476.82 | |
| 82607 | <1% | 165 | $451.28 | |
| 87660 | <1% | 144 | $435.01 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 21 | $433.90 |
| 87640 | <1% | 25 | $426.63 | |
| 73070 | <1% | 28 | $400.55 | |
| 86780 | <1% | 137 | $399.43 | |
| 80175 | <1% | 34 | $365.12 | |
| 84439 | <1% | 401 | $317.25 | |
| 82570 | <1% | 413 | $272.11 | |
| 81001 | <1% | 433 | $261.44 | |
| 85007 | <1% | 252 | $253.82 | |
| 82043 | <1% | 184 | $233.77 | |
| 86850 | <1% | 102 | $227.01 | |
| 83540 | <1% | 394 | $218.58 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 765 | $166.58 |
| 84402 | <1% | 72 | $116.73 | |
| 83516 | <1% | 62 | $106.77 | |
| 83993 | <1% | 12 | $102.08 | |
| 73090 | <1% | 20 | $97.92 | |
| 86140 | <1% | 243 | $94.79 | |
| 83615 | <1% | 153 | $74.18 | |
| 85651 | <1% | 181 | $58.54 | |
| 81002 | <1% | 39 | $49.68 | |
| 84702 | <1% | 15 | $43.13 | |
| 83735 | <1% | 42 | $35.27 | |
| 86901 | <1% | 88 | $35.01 | |
| 82950 | <1% | 26 | $34.23 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 24 | $28.47 |
| 86900 | <1% | 100 | $25.88 | |
| 82784 | <1% | 33 | $22.10 | |
| 82746 | <1% | 13 | $11.16 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 17 | $4.40 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 29 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 80 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 124 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWELDAY, DOUGLAS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Northshore University Healthsystem | Skokie, IL | $2.69M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.